Product NDC: | 51079-902 |
Proprietary Name: | Loxapine |
Non Proprietary Name: | loxapine |
Active Ingredient(s): | 25 mg/1 & nbsp; loxapine |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 51079-902 |
Labeler Name: | UDL Laboratories, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076762 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110809 |
Package NDC: | 51079-902-20 |
Package Description: | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-902-20) > 1 CAPSULE in 1 BLISTER PACK (51079-902-01) |
NDC Code | 51079-902-20 |
Proprietary Name | Loxapine |
Package Description | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-902-20) > 1 CAPSULE in 1 BLISTER PACK (51079-902-01) |
Product NDC | 51079-902 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | loxapine |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20110809 |
Marketing Category Name | ANDA |
Labeler Name | UDL Laboratories, Inc. |
Substance Name | LOXAPINE SUCCINATE |
Strength Number | 25 |
Strength Unit | mg/1 |
Pharmaceutical Classes |